Journal of the National Comprehensive Cancer Network

简称 J NATL COMPR CANC NE ·UNITED STATES ·出版周期 Monthly ·年均收录 129 篇

16.4

最新影响因子

1.30%

自引率

投稿难度

偏慢,4-8周

审稿周期

期刊简介

Journal of the National Comprehensive Cancer Network（ISSN号1540-1405）是一本由美国国家综合癌症网络（NCCN）出版的月刊，出版地为美国，出版商为NCCN，2022年影响因子为12.693，非开放获取（OA）期刊，被SCI收录，中科院分区为医学1区。该杂志主要发表与癌症诊断、治疗和预防相关的临床实践指南、原创研究、综述和评论，重点关注多学科综合治疗和循证医学，发文特点为内容权威且实用性强，旨在为临床医生提供最新的癌症诊疗建议。杂志质量较高，因其与NCCN的紧密关联而具有较高的学术影响力，但可能存在偏重美国临床实践的风险，国际普适性需结合本地指南评估。

影响因子趋势

近期发表

Comparative Cost-Effectiveness Analysis of First-Line Immunotherapy for Advanced Melanoma Based on 10-Year Clinical Outcomes 2026-09-03

New Paradigms in the Management of Castleman Disease 2026-09-01

Fostering Improvements in Equitable Care Delivery: Insights From the Health Equity Report Card (HERC) Pilot in Academic Cancer Centers 2026-08-27

County-Level Medical Debt and Its Associations With Cancer Stage and Survival in the United States 2026-08-18

Metabolic Tumor Volume as a Predictor of Benefit From Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer 2026-08-13

Technology-Enabled Patient and Physician Activation to Enhance Skin Cancer Screening After HCT: A Randomized Controlled Trial 2026-08-06

Incorporating the Next Generation of Immunotherapies Into the Treatment of Multiple Myeloma 2026-05-26

Authors’ Reply to the Letter to the Editor by Batalini et al: Observational Data on Vitamin D Do Not Justify Routine Screening or Supplementation to Improve Breast Cancer Outcomes 2026-08-17

Measuring Equitable Care Delivery: Insights From the Health Equity Report Card (HERC) Pilot in Academic Cancer Centers 2026-07-02

Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology 2026-08-17